Literature DB >> 17194827

In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.

Emilia Cercenado1, Mercedes Marín, Mónica Sánchez-Martínez, Oscar Cuevas, José Martínez-Alarcón, Emilio Bouza.   

Abstract

The in vitro activities of tigecycline and other antimicrobials against 51 isolates of Nocardia spp. were evaluated. MIC(90)s and MIC ranges were as follows: tigecycline, 4 and < or =0.06 to 8 mg/liter, respectively; minocycline, 2 and < or =0.06 to 2 mg/liter, respectively; linezolid, 1 and < or =0.06 to 2 mg/liter, respectively; moxifloxacin, 2 and < or =0.06 to >64 mg/liter, respectively; ertapenem, 32 and < or =0.06->64 mg/liter, respectively; imipenem, 2 and < or =0.06 to >64 mg/liter, respectively; meropenem, 8 and < or =0.06 to >64 mg/liter, respectively; amikacin, 1 and < or =0.06 to 32 mg/liter, respectively; and trimethoprim-sulfamethoxazole, 1/19 and < or =0.5/9.5 to >2/38 mg/liter, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194827      PMCID: PMC1803140          DOI: 10.1128/AAC.01102-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Nocardiosis: review of clinical and laboratory experience.

Authors:  Michael A Saubolle; Den Sussland
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  Antimicrobial susceptibility patterns of Nocardia asteroides.

Authors:  R J Wallace; L C Steele; G Sumter; J M Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

Review 3.  Linezolid: an oxazolidinone antimicrobial agent.

Authors:  H B Fung; H L Kirschenbaum; B O Ojofeitimi
Journal:  Clin Ther       Date:  2001-03       Impact factor: 3.393

4.  Identification of nocardia species by restriction endonuclease analysis of an amplified portion of the 16S rRNA gene.

Authors:  P S Conville; S H Fischer; C P Cartwright; F G Witebsky
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.

Authors:  Y Glupczynski; C Berhin; M Janssens; G Wauters
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

Review 6.  Oxazolidinone antibiotics.

Authors:  D J Diekema; R N Jones
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

7.  Evaluation of E test, disk diffusion and broth microdilution to establish tentative quality control limits and review susceptibility breakpoints for two aerobic actinomycetes.

Authors:  P Tomlin; C Sand; R P Rennie
Journal:  Diagn Microbiol Infect Dis       Date:  2001-08       Impact factor: 2.803

8.  Sequence-based identification of aerobic actinomycetes.

Authors:  Jean Baldus Patel; Richard J Wallace; Barbara A Brown-Elliott; Tony Taylor; Carol Imperatrice; Deborah G B Leonard; Rebecca W Wilson; Linda Mann; Kenneth C Jost; Irving Nachamkin
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

9.  In vitro activities of new antimicrobials against Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Eva Gonzalez; Sung H Choi; Oliverio Welsh
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

10.  In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis.

Authors:  Alejandra Gomez-Flores; Oliverio Welsh; Salvador Said-Fernández; Gerardo Lozano-Garza; Roman Erick Tavarez-Alejandro; Lucio Vera-Cabrera
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

View more
  23 in total

1.  Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents.

Authors:  Julián Larruskain; Pedro Idigoras; José M Marimón; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

2.  Retroperitoneal abscesses due to Nocardia farcinica: report of two cases in patients with malnutrition.

Authors:  E de Montmollin; O Corcos; L Noussair; V Leflon-Guibout; N Belmatoug; F Joly; A Lefort
Journal:  Infection       Date:  2011-08-23       Impact factor: 3.553

3.  Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis.

Authors:  Lisa R McTaggart; Jennifer Doucet; Maria Witkowska; Susan E Richardson
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

4.  Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.

Authors:  Chih-Cheng Lai; Wei-Lun Liu; Wen-Chien Ko; Yen-Hsu Chen; Hon-Ren Tan; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

Review 5.  Nocardiosis: updates and clinical overview.

Authors:  John W Wilson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

6.  Nocardial endocarditis in native aortic valve with nocardial sepsis in a case of breast cancer.

Authors:  Sudeep Gupta; Seema Gulia; Ram Abhinav Kannan; Camilla Rodrigues; Jayesh Dhareshwar; Amit Vora
Journal:  BMJ Case Rep       Date:  2019-07-11

7.  Molecular identification and susceptibility pattern of clinical Nocardia species: Emergence of Nocardia crassostreae as an agent of invasive nocardiosis.

Authors:  Saad J Taj-Aldeen; Anand Deshmukh; Sanjay Doiphode; Atqah Abdul Wahab; Mona Allangawi; Ahmed Almuzrkchi; Corné H Klaassen; Jacques F Meis
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

8.  Nocardia cyriacigeorgica, an emerging pathogen in the United States.

Authors:  Robert Schlaberg; Richard C Huard; Phyllis Della-Latta
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948

9.  Molecular identification and antibiotic resistance pattern of actinomycetes isolates among immunocompromised patients in Iran, emerging of new infections.

Authors:  Hossein Ali Rahdar; Shahram Mahmoudi; Abbas Bahador; Fereshteh Ghiasvand; Fatemah Sadeghpour Heravi; Mohammad Mehdi Feizabadi
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

10.  Empyema necessitans with osteomyelitis of fifth rib due to Nocardia farcinica: a case report.

Authors:  Swapnil Tripathi; Durga Shankar Meena; Amit Kumar Rohila; Neetha T R; Vidhi Jain; Deepak Kumar; Taruna Yadav; Mahendra Kumar Garg
Journal:  BMC Infect Dis       Date:  2021-08-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.